Related Experiment Video
Updated: Jun 25, 2026
11:11
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
Published on: February 11, 2022
[Research Progress and Application Prospects of Saliva-Based Point-of-Care Testing Technologies]
Qian Dou1,2,3, Liping Zhu1,2, Jiaying Ni4
1Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing, 100190.
Summary
Point-of-care testing (POCT) for saliva offers a non-invasive method for disease screening. This review covers diverse POCT technologies for salivary biomarkers, highlighting their potential for clinical application.
Area of Science:
- Biomarker Discovery
- Diagnostic Technologies
- Clinical Chemistry
Background:
- Saliva is a valuable biological fluid for monitoring physiological and pathological conditions.
- Its ease of collection, safety, and non-invasive nature make it ideal for diagnostics.
- Point-of-care testing (POCT) is crucial for rapid, accurate, and cost-effective salivary diagnostics.
Purpose of the Study:
- To systematically review recent advancements in POCT technologies for salivary biomarkers.
- To analyze the technical principles, design, performance, and applications of various POCT methods.
- To identify challenges and opportunities for the clinical translation of saliva POCT.
Main Methods:
- Review of diverse POCT technologies: dry chemistry, immunochromatography, chemiluminescence, electrochemistry, QCM, SPR, microfluidics, biochips, molecular diagnostics, and AI-assisted diagnostics.
- Focus on commercially available or translationally potential technologies.
- Analysis of technical principles, design concepts, performance metrics, and application scenarios.
Main Results:
- Comprehensive overview of cutting-edge saliva POCT technologies.
- Detailed examination of representative methods with translational potential.
- Assessment of current capabilities and limitations of various diagnostic approaches.
Conclusions:
- Saliva POCT technologies are rapidly evolving, offering promising diagnostic solutions.
- Key challenges remain in clinical translation, including standardization and regulatory hurdles.
- Future opportunities lie in further research, technological integration, and industrial development for widespread clinical adoption.
